Shorter, daily dialysis reduces need for blood pressure medication

June 9, 2014

A clinical trial led by Drs. Deb Zimmerman and Kevin Burns shows that fewer medications are needed to control blood pressure just as effectively when patients undergo daily two-hour hemodialysis sessions. The conventional treatment is three times a week for four-hours. More than 80% of patients on dialysis have high blood pressure and more than half of patients with end-stage kidney disease die from cardiovascular disease, for which high blood pressure is a leading risk factor. Determining what mechanisms are at work in reducing the need for blood pressure medication requires further study. Read the Plos One paper.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Paddy Moore
Communications and Public Relations
Ottawa Hospital Research Institute
613-737-8899 x73687
613-323-5680 (cell)